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Abstract
Background: Knowledge of antigen-specific CD4+ T cells frequencies is pivotal to the choice of the antigen to be used in
anti-viral and anti-tumor vaccination procedures and for monitoring of immune responses. Methods that employ small cell
numbers from patient samples, are easy to perform and do not require complex techniques/instrumentations and therefore
standardization are desirable.
Methodology/Principal Findings: Purified blood CD4+ T cells from healthy donors were cultured with autologous antigen
presenting cells in several replicate wells in equal numbers in the absence (un-stimulated wells) or in the presence of
synthetic peptides corresponding to viral antigens promiscuous HLA-DR epitopes (antigen-stimulated wells). At day 7 of
culture low dose IL-2 was added and at day 14 IFN-c and IL-5 release in the supernatant was measured. A statistical analysis
approach, based on Poisson distribution, was then implemented to calculate the frequency of viral-specific CD4+ T cells. We
first determined a patient-specific exceptionality threshold of cytokine release in the un-stimulated wells and then, based on
this threshold, we counted the inactive/active wells within the antigen-stimulated wells. This number, along with the
number of cells per well, allowed the point and interval estimates of frequencies. A ready-to-use Excel worksheet template
with automatic calculations for frequencies estimate was developed and is provided as a supplemental file (Table S9).
Conclusions/Significance: We report a simple experimental procedure combining short term in vitro cell culture with
statistical analysis to calculate the frequency of antigen-specific CD4+ T cells. The detailed experimental procedure along
with the Excel applicative are a valuable tool for monitoring immune responses in the clinical practice.
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Introduction
Ag-specific CD4+ T cells play an important role in induction
and regulation of anti-viral and anti-tumor immunity [1,2,3,4]. In
the last years preventive and therapeutic vaccination strategies
using viral and tumor antigens (Ags) have been developed aiming
at activation of naı¨ve or expansion of spontaneous viral and tumor
Ag-specific memory CD4+ T cells; leading to the first FDA
approved therapeutic antitumor vaccine [5].
A fundamental requisite for clinical efficacy of anti-viral and
anti-tumor vaccines is the induction/expansion of Ag-specific
CD4+ T cells; therefore, pre- and post- vaccination immune
monitoring should evaluate and compare the presence, frequency,
phenotype and function of Ag-specific CD4+ T cells. Furthermore,
monitoring of spontaneous Ag-specific CD4+ T cell responses
prior to vaccination is also instrumental to the choice of the
immunogen to be used [6].
Different methods to detect viral and tumor Ag-specific CD4+ T
cells in healthy carriers or infected individuals and neoplastic
patients are being used (i.e., ELISPOT assay, intracellular cytokine
detection by flow cytometry, proliferation and cytokine release
assays, tetramer staining and limiting dilution assay) with different
pros and cons [7,8,9,10,11,12,13,14]. Therefore, it is important to
tailor the method to use for immune-monitoring purposes by
taking into consideration the specific vaccination strategy and the
clinical setting you need to monitor.
An important issue to consider when the different methods are
compared is the possibility to detect Ag-specific CD4+ T cells
directly ex-vivo, because of the possible biases derived from cell
culture. However, spontaneous Ag-specific CD4+ T cells are
present at very low frequencies in peripheral blood [15] and in vitro
expansion is usually needed to allow their detection. Nonetheless,
culture conditions should avoid excessive manipulation with
multiple re-stimulations in vitro with the relevant Ags to better
preserve the in vivo Ag-specific CD4+ T cell functional character-
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istics. Moreover, best characteristics for a large scale immune
monitoring approach in a clinical setting should be on the one
hand feasible with small cell samples, no cumbersome, no
expensive and with no need of a sophisticated and difficult to
standardize instrumentation and on the other hand to be the most
informative such as able to detect both the frequency and possibly
multiple functions of Ag-specific memory CD4+ T cells.
In the present study we describe a short-term in vitro re-
stimulation culture method combined with an ad hoc statistical
analysis for the calculation of the frequency of Ag-specific memory
CD4+ T cells. To this aim first we implemented a culture method
previously set for detection of the presence and quality of
spontaneous viral and tumor Ag-specific CD4+ T cells in the
blood of healthy individuals and neoplastic patients [16,17,18,19].
Second, we developed an improved statistical analysis based on the
Poisson distribution that allowed us to set the calculation for the
estimate of point and interval frequencies (i.e., the quantity) of Ag-
specific CD4+ T cells.
Materials and Methods
Donors and Antigens
Peripheral blood mononuclear cells (PBMCs) were obtained
from the blood of 17 healthy donors. The Institutional Ethics
Committee (Comitato Etico Fondazione Centro San Raffaele del
Monte Tabor, Istituto Scientifico Ospedale San Raffaele) had
approved the study protocol and written informed consent was
obtained from all donors before blood sampling. Sequence 307–
319 from influenza hemagglutinin (HA) (HA307–319) and sequence
280–294 from Epstein-Barr nuclear antigen (Ag) 2 (EB-
NA2)(EBNA2280–294) were selected as highly promiscuous HLA-
DR binders (i.e., able to bind to several alleles) [20] to be used for
recognition by CD4+ T cells from HLA-DR unselected donors (i.e.,
bearing disparate HLA-DR alleles). Synthetic peptides corre-
sponding to the selected sequences were synthesized by the
stepwise solid-phase method as described previously [21]. The
peptides were lyophilized, reconstituted in DMSO at 10 mg/ml,
and diluted in RPMI 1640 (BioWhittaker) to the final concentra-
tion of 10 mg/ml. Keyhole limpet hemocyanin (KLH) (Calbio-
chem) was used at 10 mg/ml.
Short-term Cultures of Ag-specific CD4+ T Cells
Culture for identification of responsive donors. The
culture conditions were as previously described [16,18,19] with
slight modifications. Briefly, frozen CD4+ T cells purified from
PBMCs by magnetic beads (Miltenyi Biotec) were thawed and
cultured in 96-well round-bottom plates at 16105/well in six
replicates for each condition in 200 ml/well of tissue culture
medium, composed by X-VIVO 15 (BioWhittaker) supplemented
with penicillin (100 U/ml; BioWhittaker), streptomycin (50 mg/
ml; BioWhittaker) and 3% heat-inactivated pooled human serum
(BioWhittaker), in the presence of irradiated CD4+ T cell-depleted
PBMCs as antigen presenting cells (APCs), at a CD4+ T cell : APC
ratio of 1:3. In some experiments, as detailed in the Results, cells
were plated at 1–36104/well. Stimuli were: phytohemagglutinin
(PHA) (10 mg/ml; Sigma-Aldrich), as positive control; KLH
(10 mg/ml) and viral peptides (HA307–319 and EBNA2280–
294)(10 mg/ml). CD4
+ T cells in the presence of the APCs only
were used as baseline (un-stimulated). At day 7, half medium from
each well was removed and replenished with fresh medium
containing IL-2 (25 IU/ml; R&D Systems) without further Ag
stimulation. At day 14, 100 ml of supernatant collected from each
well of the six replicates for each condition were pooled (6-wells
pool) and used for detection of IFN-c and IL-5 by ELISA
(Mabtech), according to the manufacturers’ instructions. Samples
from Ag-stimulated CD4+ T cells (pooled supernatants of
stimulated-wells) were considered positive if at least double of
the values from un-stimulated cells (pooled supernatants of un-
stimulated wells) and above 50 pg/ml. For proliferation assay
single wells were pulsed for 16 hours with [3H]TdR (1 mCi per
well, 6.7 Ci/mol; Amersham Corp.) and cells collected with a
FilterMate Universal Harvester (Packard Instruments) in specific
plates (Unifilter GF/C; Packard). Incorporated thymidine was
measured in a liquid scintillation counter (TopCount NXT;
Packard).
Culture for calculation of the frequency of Ag-specific
CD4+ T cells. Culture conditions were similar to those
described above with slight modification. Specifically, the total
number of cells tested per each condition (2 and + Ag) was 96105,
36104/well for a total of 30 wells. In one experiment (as indicated
in the Results), total cells seeded were 56105, 16104/well for a
total of 50 wells. IFN-c and IL-5 release was detected by ELISA as
described above but on single wells.
CD4+ T cell stimulation assays for Ag
specificity. Peptide-stimulated CD4+ T cells at day 21 of
culture were collected, washed and re-plated (16104/well) in
triplicate in 96-well-round-bottom plates in the presence of
irradiated autologous PBMCs (1:5), as APCs, and the relevant
peptide (10 mg/ml). Three wells with CD4+ T cells plus APCs did
not receive any stimulus to determine the basal condition. After
48 hours, IFN-c and IL-5 release was measured in the culture
supernatant by ELISA as described above.
Statistical Analysis
Exceptionality threshold. We first studied the distribution
of the cytokines concentration in the un-stimulated wells in order
to detect and exclude possible outliers and then to compute a
threshold beyond which an observation would result from such a
distribution with a very low probability (say e). Once the threshold
has been established, if the cytokines concentration in an Ag-
stimulated well is over such a threshold we conclude that the well is
activated. In order to compute this exceptionality threshold we
used the Cantelli’s inequality [22].
Estimate of frequency of Ag-specific CD4+ T cells. We
based our analysis on the assumption that the number M of
activated cells in each well containing N cells follows a Poisson
distribution with parameter f :N where f is the frequency of Ag-
specific cells that we want to estimate. The data available to
estimate the frequency f are observations by a Bernoulli variable,
which is equal to 1 if the well is declared inactive (using the
procedure proposed above) and 0 if the well is declared active. The
probability for a well to be inactive is equal to the probability that
M=0 and so is e{f
:N . Therefore, we can model the activation
data of the wells as observations from a sample of independent and
identically distributed Bernoulli variables Yi with parameter e
{f :N .
Point estimation. The maximum likelihood estimation of f is
equal to
f^~
{ ln (y)
N
, being y~
y0
n
~
#inactive wells
#total wells
,
where y0 is the number of inactive wells, n is the number of wells
and N the number of cells in each well.
Interval estimation. We used the Clopper-Pearson [23]
confidence interval for an unknown proportion p: the confidence
interval of level (1-a), when y0 = 1, 2, …, n-1 is
Frequency Estimate of Antigen-Specific CD4 T Cells
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where Fc (a, b) is the quantile of order c for a Fisher distribution
with (a, b) degrees of freedom. From equation (1) we can deduce
the confidence interval of level (1-a) for f:
1
N
ln 1z
n{y0
(y0z1)F1{a=2(2(y0z1),2(n{y0))
 
vf
v 1
N
ln 1z
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When y0= n or y0= 0 the previous confidence interval in (1)
becomes meaningless and in these extreme cases we can use the
rule of three (see [24] for more details) to construct a 95%
confidence level for f:
1{
3
n
ve{fNv1
 
and so 0vfv{ 1
N
ln 1{
3
n
  
:
This means that when y0= n (all wells are inactive), the point
estimation of the frequency of Ag-specific CD4+ T cells is zero, but
in a number of independent observations (i.e., experiments), we
expect that in 95% cases the frequency could range up to the
upper extreme of the confidence interval. Analogously, when all
cultures result active (y0 = 0), the 95% confidence interval for f,
constructed using the rule of three becomes:
0ve{fNv 3
n
 
and so {
1
N
ln
3
n
 
vfvz?
 
:
Results
Setting Culture Conditions for the Study of Ag-specific
Memory CD4+ T Cell Responses
We took advantage of the ex-vivo re-stimulation assay developed
in our laboratory to test the presence and the quality (i.e., the
cytokine profile) of anti-viral and anti-tumor recall CD4+ T cell
responses in healthy donors and neoplastic patients [16,18,19]. In
this assay 36104 purified CD4+ T cells are cultured with
autologous APCs in six replicates for each condition in the
absence and in the presence of relevant peptide(s) for a week; at
day 7, half of the medium from each well is removed and
replenished with fresh medium containing low doses IL-2. At day
14, cytokine release in the supernatant of the six pooled wells for
each condition and 3H-thymidine incorporation for single well are
measured. For cytokine release assays, samples from peptide-
stimulated wells are considered positive if at least double of the
values from un-stimulated wells and above 50 pg/ml. For the 3H-
thymidine incorporation assays, responses are considered positive
when significantly higher than the un-stimulated wells (i.e.,
CD4+APC), as determined by unpaired, one-tailed Student’s t
test. As before day 14 usually neither cytokine release nor
proliferation are detectable, we assumed that the assay allows the
expansion of in vivo activated, low frequency memory CD4+ T
cells. This assumption was supported by the lack of reactivity of
cord blood naı¨ve CD4+ T cells to peptides corresponding to
sequences of the E6 and E7 proteins of the human papilloma virus
type-18, which we otherwise showed to be immunogenic in
infected healthy individuals and cervical cancer patients [16,17].
In the present study, to definitely exclude that our culture
system induces in vitro priming of T cell responses, CD4+ T cells
purified from the blood of 7 adult healthy donors were stimulated
with the primary antigen KLH. To increase the possibility to
detect KLH specific CD4+ T cells we increased the number of
total plated cells to 2.4–4.86106 cells (16105/well in several
replicate wells). This number was chosen large enough in order to
be confident to possibly detect Ag-specific naı¨ve CD4+ T cells,
which have been recently demonstrated to range in few to 70 per
million CD4+ naı¨ve T cells [25,26]. We found that none of the
donors showed KLH-specific CD4+ T cell reactivity in terms of
both cytokine release (IFN-c and IL-5) and proliferation (Fig. 1);
even when cultures were prolonged till day 21 to increase the
chances to expand more rare precursors.
After establishing that our culture system does not induce in
vitro priming of naı¨ve CD4+ T cells, we screened 8 healthy
donors to identify suitable donors for further analysis of Ag-
specific T cell frequency. As Ags we chose two peptides
corresponding to the promiscuous viral sequences HA307–319
and EBNA2280–294 (from now on referred as HA and EBNA2,
respectively) because we previously found that these peptides
were recognized by up to almost 80% of subjects tested,
independently of the HLA-DR alleles carried [19]. We found
HA and/or EBNA2 specific CD4+ T cells in all but one donor,
although the level of cytokine released varied among them. As
an example, in Fig. 2A, we report the results obtained with
donors #8 and #9 displaying clearly different levels of IFN-c
release in the presence of the EBNA2 peptide. To prove that in
both cases we were measuring Ag-specific CD4+ T cells we
perform a specificity assay. CD4+ T cells stimulated with
EBNA2 were collected, washed, and tested for IFN-c release in
the absence or in the presence of the peptide (Fig. 2B). In both
cases IFN-c release was significantly higher in the presence than
in the absence of the peptide, demonstrating the EBNA2
specificity, and the level of cytokine released mirrored the
differential amplitude of response between the two donors
already detected in the supernatant of day 14 cultures. We
reasoned that one possible reason for the variable magnitude of
cytokine release among donors could be the presence and
expansion of a different number of EBNA2-specific CD4+ T
cells originally present in the cultures. In this case, the 14-day
culture system could be exploited for the calculation of Ag-
specific CD4+ T cell frequency by application of the Poisson
distribution, considering that at least one Ag-specific CD4+ T
cell should be present in each positive well. Thus, we repeated
the culture from the same two donors maintaining the total
number of cells tested (66105) but with two different
concentrations of cells/well (i.e., 16104 and 36104, respectively)
and performed single-well INF-c detection. Five and ten wells
per conditions, respectively, were left un-stimulated to determine
the background level of cytokine release. Ag-stimulated wells
were considered positive if IFN-c release was 2-fold higher than
the mean value of the un-stimulated wells. In both cell-plating
densities the number of positive wells within the Ag-stimulated
was higher for donor #8 (14 and 25, respectively) than donor
#9 (8 and 12, respectively)(Fig. 2C). We concluded that indeed
our culture system could be exploited also for frequency
estimation.
Frequency Estimate of Antigen-Specific CD4 T Cells
PLoS ONE | www.plosone.org 3 August 2012 | Volume 7 | Issue 8 | e42340
Statistical Basis and Experimental Validation for the
Analysis of CD4+ T cell Frequencies
A major concern when applying the culture system described
above is the identification of a threshold of cytokine release by un-
stimulated cells that would guarantee discriminating between Ag-
Figure 1. The in vitro re-stimulation culture used does not
induce priming of naı¨ve CD4+ T cells. Total CD4+ T cells were
purified from the blood of adult healthy donors and put in culture
(16105/well) in several replicates in the absence (no Ag=CD4+APCs) or
in the presence of the primary Ag KHL. PHA stimulation was used as
positive control. At days 14 (d14) and 21 (d21) supernatants were
collected and groups of six wells were pooled and IFN-c and IL-5 release
quantified by ELISA. For 3H-thymidine incorporation assays data from
each well are shown.
doi:10.1371/journal.pone.0042340.g001
Figure 2. The amount of IFN-c released by CD4+ T cells
correlates with the number of positive wells. Healthy donors
(HD) #8 and #9 were chosen as representative for donors with
different amplitude of IFN-c release by viral Ag-stimulated CD4+ T cells.
(A) 16105/well CD4+ T cells were cultured with autologous APCs in the
absence (6 wells) and in the presence (6 wells) of the EBNA2 peptide.
IFN-c release was measured at days 14 (white columns) and 21 (grey
columns) of culture on supernatant pools of the 6 wells. Values are the
means of duplicate determinations 6 SEM. (B) After a further week of
culture (d21), EBNA2-stimulated CD4+ T cells were collected, washed
and tested for EBNA2-specific recognition by challenge with un-pulsed
or peptide-pulsed autologous APCs and IFN-c specific release was
measured after 48 hours. Values are the means of triplicate
determinations 6 SEM. Responses significantly higher than the blanks
(i.e., no Ag = CD4+APC) are indicated as ***p,0,001 (determined by
unpaired, one-tailed Student’s t test). (C) CD4+ T cells from the same
Frequency Estimate of Antigen-Specific CD4 T Cells
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specific and non Ag-specific CD4+ T cells activation and function.
Thus, we decided to further modify the experimental procedure
(Fig. 3) by enlarging the number of un-stimulated wells, on which
to perform statistical analysis to set a proper threshold of unspecific
cytokine release. A total of 186105 CD4+ T cells from 7 donors
were seeded in 60 wells at 36104/well. Half wells were left un-
stimulated (2Ag) and half were stimulated with the relevant
peptide(s)(+Ag). IFN-c and IL-5 release was assayed at day 14 of
culture in each independent well. Data of cytokines release for
each donor are reported in Tables S1, S2, S3, S4, S5, S6, S7.
Outlier exclusion and exceptionality threshold in the un-
stimulated wells. The basal activation state of CD4+ T cells in
the absence of peptide-specific stimulation is extremely variable
among donors (Tables S1, S2, S3, S4, S5, S6, S7), therefore
criteria to define donor-specific thresholds must be defined. We
studied the distribution of cytokines concentration in the un-
stimulated wells in order to detect and exclude possible outliers
and to set a threshold for single-well cytokines release to be used to
discriminate between un-specific and Ag-stimulated cultures.
We considered as outliers all data over the value Q3+1.5*(Q3-
Q1), where Q1 is the quantile of order 25% and Q3 the quantile
of order 75% of the distribution of un-stimulated wells cytokines
concentration and excluded these data in the following analyses.
We then computed an exceptionality threshold, based on the
Cantelli’s inequality, beyond which an observation would belong
to the distribution of the un-stimulated wells with a very low (i.e.,
exceptional) probability (e). The Cantelli’s inequality states that for
a random variable X, with mean m and standard deviation s, for
every k.0 we have:
P(X{m§ks)ƒ 1
1zk2
In particular, if we set
~k~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
e
{1,
r
the previous inequality becomes
P(X{m§~ks)ƒe[P(X§mz~ks)ƒe[P(X§Th)ƒe
where Th~mz~ks: Th is the exceptionality threshold and m and s
are the mean and the standard deviation of the X distribution. In
our case we estimated m and s using the values of the cytokines
concentration of the un-stimulated wells after discarding the
outliers. If, as an example, we choose as value of very low
probability e=0.05 then ~k~4:36 and we will assign all values of
cytokines concentration over the threshold Th~mz4:36  s to an
Ag-stimulated well because such values would derive from an un-
stimulated well only with a low probability. As a consequence,
considering the Ag-stimulated wells, when the cytokine concen-
tration is over the exceptionality threshold Th, the well will be
declared active (i.e., Ag-activated).
Table 1 reports the calculation of independent exceptionality
thresholds for IFN-c and IL-5 release at day 14, based on the
estimate of the mean m and the standard deviation s of the
distribution of the basal cytokine production in the un-stimulated
wells (without outliers). An example of the distribution of IFN-c
and IL-5 basal values of the un-stimulated wells for a represen-
tative donor (#12) is also reported in Fig. 4. In this example, the
quartile of the distribution of IFN-c concentration in the un-
stimulated wells are Q1= 9.07, Q2= 15.65 and Q3=37.57. The
data over Q3+1.5* (Q3-Q1)(in this example equal to 80.32) are the
outliers. The mean m of the non outliers is 18.66 and the standard
deviation s is 13.6, so setting e=0.05, k is 4.36 and the
exceptionality threshold Th is 18.66+4.36*13.60= 77.93. There-
fore, the Ag-stimulated wells in which IFN-c release is greater or
equal to 77.93 can be declared active. For IL-5 the quartile of
concentration distribution in the un-stimulated wells are
Q1=6.00, Q2= 9.50 and Q3=21.25. The data over Q3+1.5*
(Q3-Q1)(in this example equal to 44.12) are the outliers. The
mean m of the non outliers is 10.77 and the standard deviation s is
8.23, so setting e=0.05, k is 4.36 and the exceptionality threshold
Th is 10.77+4.36*8.23= 46.63. Therefore, the Ag-stimulated wells
in which IL-5 release is greater or equal to 46.63 can be declared
active. The values of the thresholds in the un-stimulated wells for
each donor, reported in Table 1, were then used to calculate the
number of inactive wells for IFN-c and IL-5, respectively, in the
HA- and EBNA2-stimulated wells (Table S8).
Estimation of the Frequency of Ag-activated Cytokine-
producing CD4+ T cells
Point and interval estimation. After having established for
each donor the exceptionality threshold (Table 1), the number of
inactive/active in the Ag-stimulated wells (Table S8) and the
number of cells per well (reported in Tables S1, S2, S3, S4, S5, S6,
S7), to calculate the frequency of Ag-stimulated CD4+ T cells we
applied the estimation procedure reported in the Materials and
Methods: the results are reported in Table 2 and Table 3.
To take into account the inter-experimental variability we
decided also to provide interval estimation of the values of the
frequency. To this aim we applied the Clopper-Pearson method to
define a confidence interval of level (1-a) for the frequency f. The
confidence interval length decreases as the number N of seeded
two donors were cultured plating two seeding densities, i.e.
36104 cells/well (5 un-stimulated wells and 20-stimulated wells) (upper
panels) and 16104 cells/well (10 un-stimulated wells and 60 stimulated
wells)(lower panels). At day 14, IFN-c secretion was measured as above
but on single well supernatants. Dots are means of duplicate
determinations.
Figure 3. Schematic representation of the culture conditions
set for estimate of Ag-specific CD4+ T cells frequency. CD4+ T
cells were purified from total PBMCs and seeded in 96-well plates at
36104/well in the presence of irradiated autologous APCs (1:3 ratio) for
a total of 0.96106 CD4+ T cells for each condition, i.e., in the absence
(2Ag) or in the presence (+Ag) of the relevant peptide. At day 7, low
dose IL-2 was added without further Ag stimulation. At day 14, single-
well cytokine release (IFN-c and IL-5) was measured by ELISA.
doi:10.1371/journal.pone.0042340.g003
Frequency Estimate of Antigen-Specific CD4 T Cells
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cells augments and with increasing numbers of inactive wells (y0).
For our purposes, a 95% confidence interval was chosen,
corresponding to a=0.05.
Figure 5 reports box and whisker plots of cytokines distribution
in the un-stimulated and in the Ag-stimulated wells for both IFN-c
(Fig. 5A, left) and IL-5 (Fig. 5A, right) in donors representative of
higher and lower frequency of viral-specific CD4+ T cells (Fig. 5B).
The estimates of interval frequencies for all donors were calculated
and are reported along with the punctual ones in Table 2 and
Table 3.
Finally, we converted the proposed statistical method into a
ready-to-use Excel worksheet (Table S9), which automatically
calculate the exceptionality threshold, the point and interval
frequencies, once N (i.e., the number of seeded cells/well), e (i.e.,
the probability defining the exceptionality threshold) and a (i.e., the
confidence level of interval estimates) are set and the experimental
data from the wells are input in the columns of un-stimulated and
Ag-stimulated wells. The worksheet is designed for a maximum of
60 wells for the un-stimulated as well as for the Ag-stimulated wells
and it automatically infers the number n of wells seeded.
Discussion
We report a culture method combined with a statistical analysis
strategy that allows the estimate of low frequency Ag-specific
memory CD4+ T cells. Indeed, frequency of IFN-c secreting HA-
and EBNA2- specific CD4+ T cells as low as 0.0017% and
0.0021% of total CD4+ T cells, respectively, and frequency of IL-5
secreting HA- and EBNA2- specific CD4+ T cells as low as
0.00023% and 0.00035% of total CD4+ T cells, respectively, could
be detected in a cohort of healthy donors.
Important issues to be considered in the evaluation of the power
of a detection system are the specificity and the sensitivity.
Concerning the specificity, in our experimental protocol 0.96106
CD4+ T cells are cultured in 30 independent wells (306104/well)
with peptide-pulsed APCs and an equal number of CD4+ T cells,
distributed in the same number of wells, are cultured in the
absence of the peptide (i.e., un-pulsed APCs). The specificity
derives from the comparison between the two groups (+Ag and
2Ag), once criteria to define the background level cytokine
secretion in the 2Ag group have been established. Since
spontaneous cytokine release of CD4+ T cells in the presence of
un-pulsed APCs is heterogeneous and highly varies among
different subjects, the background level of cytokine release needs
to be tailored. In our system the background level of cytokine
secretion is established for each donor by the calculation of a
proper exceptionality threshold beyond which a value of cytokine
release would belong to the distribution of the un-stimulated wells
with a very low probability. As a consequence, all the values within
the stimulated-wells that are over this threshold (i.e., are
exceptional) are considered specifically activated. Therefore, the
introduction of the exceptionality threshold in our statistical
analysis to estimate the number of activated wells is an important
innovation because it takes into account the patient-specific
distribution of cytokines release in the un-stimulated wells.
Concerning the sensitivity, the theoretical detection limits of our
procedure depends on the total number of CD4+ T cells studied.
The condition of (n21) inactive wells in the stimulated-wells
represents the lower detection limit, because the corresponding
frequency (f=1.1361026 for 29 inactive wells out of 30) is the
lowest point estimation calculable above 0. On the other hand, the
condition of 1 inactive well in the Ag-stimulated wells represents
the upper detection limit, because the corresponding frequency
(f=1.1361024 for 1 inactive well out of 30) is the highest point
estimation. In the opposite cases of n inactive wells or 0 inactive
Table 1. Mean, standard deviation (after discarding of the
outliers) and threshold for IFN-c and IL-5 concentration at day
14 in the un-stimulated wells.
Donor # IFN-c (pg/ml) IL-5 (pg/ml)
Mean SD Threshold Mean SD Threshold
11 22.62 6.76 52.10 16.51 10.76 63.40
12 18.66 13.60 77.93 10.77 8.23 46.63
13 8.90 4.02 26.43 n.p.a n.p. n.p.
14 11.91 5.61 36.36 11.79 4.10 29.68
15 23.04 16.87 96.59 57.00 55.85 300.43
16 2.69 2.22 12.38 57.85 55.55 300.00
17 7.49 5.33 30.72 18.36 22.72 117.11
an.p., not performed.
doi:10.1371/journal.pone.0042340.t001
Figure 4. Box and whisker plots of the distribution of basal
cytokine production by CD4+ T cell cultures. The bottom and top
of the box are the 25th (Q1) and 75th percentile (Q3), the lower and
upper quartiles, respectively, and the band near the middle of the box is
the 50th percentile (the median). The ends of the whiskers represent the
smallest datum still within 1.5 the Interquartile Range (IQR=Q32Q1) of
the lower quartile, and the largest datum still within 1.5 IQR of the
upper quartile. Outliers are represented as black dots.
doi:10.1371/journal.pone.0042340.g004
Table 2. Point and interval frequencies of Ag-activated
cytokine-secreting CD4+ T cells in the HA-stimulated wells.
Donor # IFN-c IL-5
Lowera Punctual Upper Lower Punctual Upper
11 39.3 67.1 109.0 1.9 6.1 14.2
12 44.2 76.8 129.0 2.7 7.4 16.2
13 n.p.b n.p. n.p. n.p. n.p. n.p.
14 8.6 17.0 30.0 4.4 10.3 20.5
15 35.3 59.7 95.8 26.0 44.1 69.9
16 35.3 59.7 95.8 0.3 2.3 8.3
17 41.0 65.4 98.3 15.8 30.1 51.7
aLower, punctual and upper frequencies are indicated as the number of IFN-c
and IL-5 secreting cells/106 total CD4+ T cells.
bn.p., not performed.
doi:10.1371/journal.pone.0042340.t002
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wells, point estimates of frequencies are trivial, but we can
compute 95% confidence interval estimates, which have quite
broad limits. By doubling the total number of cells tested (60 wells
of 306104 CD4+ T cells/well), the lower and upper detection
limits become f=5.6061027 and f=1.3661024, respectively. In
both formats (30 and 60 wells), frequency estimate covers at least a
two-log range.
Beside the calculation of the exceptionality threshold, another
important statistical tool in our system is the calculation of both the
punctual and interval frequencies. Indeed, the calculation the
interval frequencies with the lower and the upper limits reflects the
possible range of inter-experimental variability.
Previous studies have evaluated the frequency of HA306–318-
specific CD4+ T cells of healthy normal individuals by the use
HLA class II multimers both directly ex-vivo staining and after one
week in vitro re-stimulation. One study [27] reported estimates of
DRB1*0401 tetramer-specific T cells frequencies ranging between
30 and 5061026. Another study [28], found frequencies ranging
from 1.2 to 6061026 using DRB1*0101 tetramers. A third study
[29] also reported similar frequencies using both DRB1*0401 and
DRB1*0101 tetramers. In the present study, we used the same
promiscuous HA peptide in an HLA-DR unselected population
(i.e., subjects bearing disparate HLA-DR alleles) of healthy donors
and found punctual estimate of IFN-c secreting CD4+ T cells
ranging from 17 and 7761026, which are values very much
compatible with the ones reported in the other studies. Paired
values, ranging from 2.3 and 44.161026, were found for IL-5
secreting cells. In three donors (#11, #12, and #16) the
frequency of IFN-c secreting cells highly exceeded the IL-5
secreting ones. In other three donors (#14, #15 and #17) the
frequency of IL-5 secreting cells were instead comparable or about
half of the IFN-c secreting cells, suggesting the expansion in
different donors of Th1 and Th0 or Th1/Th2 subsets. For the
EBNA2-specific CD4+ T cells we found frequencies of IFN-c
secreting cells ranging from 21 to 11361026 and from 3.5 to
Table 3. Point and interval frequencies of Ag-activated
cytokine-secreting CD4+ T cells in the EBNA-stimulated wells.
Donor # IFN-c IL-5
Lowera Punctual Upper Lower Punctual Upper
11 25.9 44.0 69.9 1.3 4.8 12.2
12 31.7 53.6 85.4 1.9 6.1 14.2
13 58.6 113.0 236.0 n.p.b n.p. n.p.
14 11.1 21.0 35.6 0.7 3.5 10.3
15 19.2 33.4 53.8 6.3 13.5 25.0
16 23.5 40.1 63.8 2.7 7.4 16.2
17 38.3 61.6 93.3 4.6 12.8 27.9
aLower, punctual and upper frequencies are indicated as the number of IFN-c
and IL-5 secreting cells/106 total CD4 T cells.
bn.p., not performed.
doi:10.1371/journal.pone.0042340.t003
Figure 5. Point and interval estimations of Ag-specific CD4+ T cells frequencies. (A) Box and whisker plots of the distribution of cytokines
(IFN-c and IL-5) release by CD4+ T cell cultures within the un-stimulated and Ag-stimulated wells of representative donors. (B) Representation of point
and interval frequencies of Ag-specific CD4+ T cells for representative donors.
doi:10.1371/journal.pone.0042340.g005
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13.561026 for IL-5. When we considered paired IFN-c/IL-5
responses in the case of EBNA2 specific CD4+ T cells the
frequency of IL-5 secreting cells was usually much lower compared
to IFN-c, suggesting that the response to EBV in these subjects was
more polarized toward a Th1 type. Although, to our knowledge
EBNA2-specific CD4+ T cell frequencies have been not reported
so far, a study [30], which evaluated the response against the
EBNA1 protein also found primarily Th1 type responses with
frequencies that were in the order of few hundreds per million cells
but in this case responses to multiple epitopes were studied.
With the advent of Ag and peptide specific vaccination
therapies, a need for immune-monitoring methods to be applied
in large scale clinical trials has emerged as a fundamental
prerequisite for correlative studies to compare induction/expan-
sion of Ag-specific immune responses and clinical efficacy [31].
Methods that are both quantitative and qualitative should be
employed. The most widely used assay is the IFN-c ELISPOT
and, recently, panels of researcher from different centers have
began important useful comparisons among laboratories in order
to harmonize the experimental protocols and read outs from
different reading instruments [32].
We believe that, although the method we describe has of course
some cons (such as the inability to detect non-proliferating/non-
expanding cells and the ex-vivo phenotype) there are several pros
that may indicate its application in large scale clinical trials that
employs as immunogens protein Ags or peptides corresponding to
promiscuous epitopes. Indeed, given that the frequencies of Ag-
specific memory CD4+ T cells are higher than those of Ag-specific
naı¨ve CD4+ T cells (the latter is in the order of few to 70 cells per
million CD4+ naı¨ve T cells [25,26]) and provided that our system
can only detect recall responses, we believe that 16106 total CD4+
T cells is a reasonable number to study most memory frequencies.
This allows the use of small PBMCs samples, usually less than
106106. The method is easy to perform and not labor-intensive, it
does not require dedicated facilities or complicated reading
instrumentations neither costly material. Results are obtained in
two weeks and multiple functional assays (i.e., cytokine arrays and
proliferation assays) can be performed. Moreover, since cells
growing in the Ag-activated wells most likely derive from the
expansion of one precursor; in the case in which proliferation
assays are not performed, growing cells can be further cultured
and easily cloned for additional functional studies.
Collectively, we describe here a method for monitoring of Ag-
specific CD4+ T cell responses that would be of advantage in large
scale clinical trials of vaccination with protein or peptide Ags. Its
use is greatly facilitated by the enclosed ready-to-use Excel
application/worksheet with integrated the statistical analysis
developed in this study.
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